In a human glioma cancer model, the expression of IL-7 was positively correlated with the IC50 of cisplatin in both cell lines and glioma patient samples, and the overexpression of IL-7 further increased cisplatin resistance in glioma cancer cells [14]. Here, IL7 is linked to central nervous system cancer.